Cephalon, Inc. (Frazer, PA) has sued Celgen Corp. (Summit, NJ) and others for infringement of Patent No. RE40,493 directed to porous paclitaxel matrices. Defendants’ Abraxane drug is specifically accused of infringing. Cephalon’s licensor is also named as a plaintiff.
Cephalon, Inc. v. Celgene Corp., 11-12226-GAO (D. Mass. Dec. 14, 2011)
Comments